Pheronym is among 25 synthetic biology companies that raised funds in 2019 Q1

Synthetic biology investment in the midwest topped the Bay Area in Q1 by John Murray at Synbiobeta

2019 Q1 report companies

Whether it’s Motown music or Boston biotech, innovation happens quicker in some places than others. And in synthetic biology, Boston and the Bay Area have always set the pace. The reasons are well known. Decades of smart policy decisions paved the way for today’s virtuous circle of innovation and investment. But Q1 funding for synthetic biology brought some surprises. Keep reading.

Leave a Reply